TrialInternational clinical psychopharmacology2017

Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study.

Keith A Wesnes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.